SCO-101

· Scandion Oncology A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCO-101, covering 2021-12-29 to 2022-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI [Phase 1, Phase 2]

See pricing